1)Siskind D, Siskind V, Kisely S:Clozapine response rates among people with treatment-resistant schizophrenia:Data from a systematic review and meta-analysis. Can J Psychiatry 62:772-777, 2017[PMID:28655284]
2)Chakrabarti S:Clozapine resistant schizophrenia:Newer avenues of management. World J Psychiatry 11:429-448, 2021[PMID:34513606]
3)Siskind DJ, Lee M, Ravindran A, et al:Augmentation strategies for clozapine refractory schizophrenia:A systematic review and meta-analysis. Aust N Z J Psychiatry 52:751-767, 2018[PMID:29732913]
4)Tracy DK, Joyce DW, Sarkar SN, et al:Skating on thin ice:Pragmatic prescribing for medication refractory schizophrenia. BMC Psychiatry 15:174, 2015[PMID:26205327]
5)Tseng PT, Chen YW, Chung W, et al:Significant effect of valproate augmentation therapy in patients with schizophrenia:A meta-analysis study. Medicine 95:1-10, 2016[PMID:26825886]
6)Yang CC, Wang XY, Chou PH, et al:Valproate-related neutropenia and lithium-related leukocytosis in patients treated with clozapine:A retrospective cohort study. BMC psychiatry 23:170, 2023[PMID:36922799]
7)Moldavsky M, Stein D, Benatov R, et al:Combined clozapine-lithium treatment schizophrenia and schizoaffective disorder. Eur Psychiatry 13:104-106, 1998[PMID:19698608]
8)Kelly DL, Conley RR, Feldman S, et al:Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. Psychiatr Q 77:81-95, 2006[PMID:16397757]
9)Aydin M, Ilhan BC, Calisir S, et al:Continuing clozapine treatment with lithium in schizophrenic patients with neutropenia or leukopenia:Brief review of literature with case reports. Ther Adv Psychopharmacol 6:33-38, 2016[PMID:26913176]
10)Reischies FM, Hartikainen J, Berghõfer A:Initial lithium and valproate combination therapy in acute mania. Neuropsychobiology 46:22-27, 2002[PMID:12571429]